The J-ALEX trial-is frontline alectinib a new standard of care?

J Thorac Dis. 2017 Aug;9(8):2242-2245. doi: 10.21037/jtd.2017.06.134.

Authors

Jeffrey Zweig¹, Heather A Wakelee¹

Affiliation

¹ Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

No abstract available

Publication types

Editorial
Comment